Keywords: سولفونیل اوره; Diabetes mellitus; Hypoglycemic agents; Glucose variability; Exercise; Sulphonylurea; Dipeptidyl peptidase-IV inhibitors;
مقالات ISI سولفونیل اوره (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سولفونیل اوره; Dipeptidyl peptidase-4 inhibitor; Ramadan fasting; Sulphonylurea; Type 2 diabetes mellitus;
Keywords: سولفونیل اوره; Drug use bias; Diabetes; Treatment failure; Metformin; Sulphonylurea;
Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE Trial
Keywords: سولفونیل اوره; Alogliptin; Cardiovascular disease; Diabetes; Hypoglycemia; Metformin; Sulphonylurea;
Effectiveness of vildagliptin versus other oral antidiabetes drugs as add-on to sulphonylurea monotherapy: Post hoc analysis from the EDGE study
Keywords: سولفونیل اوره; Real-life setting; India; Vildagliptin; Sulphonylurea;
Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes
Keywords: سولفونیل اوره; Empagliflozin; Glycaemic control; Metformin; SGLT2 inhibitor; Sulphonylurea;
The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel
Keywords: سولفونیل اوره; Diabetes; Pain; TRP channel; Dorsal root ganglion; Sulphonylurea
Characteristics of Patients With Sulphonurea-Induced Hypoglycemia
Keywords: سولفونیل اوره; Hypoglycemia; elderly; malnutrition; renal failure; sulphonylurea; type 2 diabetes mellitus;
Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden
Keywords: سولفونیل اوره; Cost-effectiveness; Utility; Economic modeling; HbA1c; Hypoglycaemia; Type 2 diabetes; Sulphonylurea; Saxagliptin; Diabetes-related complications
Decreasing postprandial C-peptide levels over time are not associated with long-term use of sulphonylurea: An observational study
Keywords: سولفونیل اوره; Type 2 diabetes; Beta-cell function; Sulphonylurea; C-peptide; Treatment; Diabète de type 2; Fonction β-insulaire; Insulinosécrétion; Sulfonylurées; Hypoglycémiantes; Peptide-C; Traitement; Ãtude longitudinale;
Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry
Keywords: سولفونیل اوره; Sulphonylurea; Glibenclamide; Gliclazide; Cancer; Type 2 diabetes
The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia
Keywords: سولفونیل اوره; Diabetic dyslipidaemia; Combination therapy; Cardiovascular risk; Metformin; Sulphonylurea; Thiazolidinediones
Can geneticists help clinicians to understand and treat non-autoimmune diabetes?
Keywords: سولفونیل اوره; Monogenic diabetes; Pharmacogenetics; MODY; Neonatal diabetes; Sulphonylurea
Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide
Keywords: سولفونیل اوره; Submaximal intense exercise; Standard treadmill testing; Type 2 diabetes; Sulphonylurea; Gliclazide
Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?
Keywords: سولفونیل اوره; Acarbose; Glinide; Glitazone; Impaired glucose tolerance; Impaired fasting glucose; Metformin; Prediabetes; Prevention; Sulphonylurea; Thiazolidinedione; Type 2 diabetes mellitus; ReviewAcarbose; Glinide; Glitazone; Intolérance au glucose; Hyperglycémie m
Comparison of the antioxidant and vascular effects of gliclazide and glibenclamide in Type 2 diabetic patients: A randomized crossover study
Keywords: سولفونیل اوره; Sulphonylurea; Endothelial function; 8iPGF2α
α-Glucosidase inhibitor reduces the progression of carotid intima-media thickness
Keywords: سولفونیل اوره; IMT; intima-media thickness; AveIMT; average IMT; MaxIMT; maximum IMT; HbA1c; hemoglobin A1c; SU; sulphonylurea; Intima-media thickness; α-Glucosidase inhibitor; Postprandial hyperglycemia;
Beta cell function and response to treatment in Nigerians with Type 2 diabetes mellitus
Keywords: سولفونیل اوره; T2DM; Type 2 Diabetes mellitus; FCP; fasting C-peptide; GSCP; glucagon-stimulated C-peptide; BMI; body mass index; WHR; waist-hip ratio; OHA; oral hypoglycaemic agents; ICA; islet cell antibodies; GAD; glutamic acid decarboxylase; LADA; latent autoimmun
Effect on glycemic control of the addition of 2.5Â mg glipizide GITS to metformin in patients with T2DM
Keywords: سولفونیل اوره; ANOVA; analysis of variance; BMI; body mass index; CBC; clinical blood chemistry; FPG; fasting plasma glucose; GITS; gastrointestinal therapeutic system; HBGM; home blood glucose monitoring; HOMA; homeostasis model assessment; UKPDS; UK Prospective Diabet
Reduced effectiveness of HMR 1098 in blocking cardiac sarcolemmal KATP channels during metabolic stress
Keywords: سولفونیل اوره; Cardiac myocytes; HMR 1098; KATP channel; Preconditioning; Sulphonylurea; Kir6.2/SUR2A; Ischemia;